Amicus Therapeutics Inc (FOLD)

Jun 18, 2025

When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Turn A Profit? - simplywall.st

Jun 18, 2025

Jun 17, 2025

Amicus Therapeutics (NASDAQ:FOLD) Hits New 52-Week LowTime to Sell? - MarketBeat

Jun 17, 2025

Jun 17, 2025

Amicus Therapeutics stock hits 52-week low at 5.79 USD By Investing.com - Investing.com Canada

Jun 17, 2025

Jun 16, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives $16.22 Average Price Target from Analysts - MarketBeat

Jun 16, 2025

Jun 14, 2025

(FOLD) Technical Data - news.stocktradersdaily.com

Jun 14, 2025

Jun 14, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Wedge Capital Management L L P NC - MarketBeat

Jun 14, 2025

Jun 12, 2025

Amicus Therapeutics: Opportunity Awaits In This Beaten Down Pharma (NASDAQ:FOLD) - Seeking Alpha

Jun 12, 2025

Jun 10, 2025

Amicus Therapeutics at Goldman Sachs Conference: Strategic Insights Unveiled By Investing.com - Investing.com Canada

Jun 10, 2025

Jun 10, 2025

Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight - Yahoo Finance

Jun 10, 2025

Jun 09, 2025

Zacks Research Issues Pessimistic Outlook for FOLD Earnings - MarketBeat

Jun 09, 2025

Jun 05, 2025

Two Sigma Investments LP Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 05, 2025

Jun 04, 2025

Pompe Disease Therapeutic Market Deep Research Report with - openPR.com

Jun 04, 2025

Jun 04, 2025

Millennium Management LLC Buys 44,449 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 04, 2025

Jun 03, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 03, 2025

Jun 03, 2025

New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda - GuruFocus

Jun 03, 2025

Jun 03, 2025

New Strong Sell Stocks for June 3rd - Yahoo Finance

Jun 03, 2025

Jun 03, 2025

Amicus (FOLD) Reports Positive Findings from PROPEL Study in Pompe Disease | FOLD Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve - GlobeNewswire

Jun 03, 2025

Jun 03, 2025

Clinical Data Reveals Treatment Advantages: 77% of Pompe Disease Patients Show Improvement with New Therapy - Stock Titan

Jun 03, 2025

Jun 03, 2025

Two Sigma Advisers LP Acquires 52,000 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jun 03, 2025

Jun 03, 2025

Cetera Investment Advisers Takes Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

Jun 03, 2025

Jun 02, 2025

How to Take Advantage of moves in (FOLD) - news.stocktradersdaily.com

Jun 02, 2025

May 31, 2025

Man Group plc Decreases Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 31, 2025

May 30, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 - GlobeNewswire

May 30, 2025

May 30, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 | FOLD Stock News - GuruFocus

May 30, 2025

May 30, 2025

Rare Disease Leader Amicus Therapeutics to Present Latest Updates at Major Healthcare Conferences - Stock Titan

May 30, 2025

May 30, 2025

Millennium Management LLC Has $4.31 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

May 30, 2025

May 30, 2025

Voloridge Investment Management LLC Sells 397,497 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 30, 2025

May 28, 2025

Squarepoint Ops LLC Purchases 753,060 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025

May 28, 2025

Neo Ivy Capital Management Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025

May 28, 2025

Woodline Partners LP Sells 726,952 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 28, 2025

May 27, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by Ameriprise Financial Inc. - Defense World

May 27, 2025

May 26, 2025

Pompe Disease Market: Epidemiology, Therapies, Companies, - openPR.com

May 26, 2025

May 26, 2025

Teza Capital Management LLC Sells 68,066 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 26, 2025

May 26, 2025

Nuveen Asset Management LLC Purchases 159,139 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 26, 2025

May 25, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

May 25, 2025

May 25, 2025

297,830 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Bought by Sovereign s Capital Management LLC - MarketBeat

May 25, 2025

May 24, 2025

Vestal Point Capital LP Acquires New Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 24, 2025

May 23, 2025

Deutsche Bank AG Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 23, 2025

May 21, 2025

Rafferty Asset Management LLC Sells 73,883 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

May 21, 2025